tiprankstipranks
Trending News
More News >
Aurinia Pharmaceuticals (AUPH)
NASDAQ:AUPH
Advertisement

Aurinia Pharmaceuticals (AUPH) Revenue

Compare
2,073 Followers

Aurinia Pharmaceuticals Revenue

Aurinia Pharmaceuticals had a revenue of 70.01M in the quarter ending Jun 30, 2025, with 12.08%. This bring the company's revenue in the last twelve months to 260.11M, Decreased 5.18%. In the fiscal year ending Dec 31, 2024, Aurinia Pharmaceuticals had annual revenue of 235.13M with 33.97% growth.
Revenue (ttm)
260.11M
Revenue Growth
25.59%
P/S Ratio
6.77
Revenue/Employee
$1,808,715
Employees
130
Market Cap
$1.59B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
235.13M59.62M+33.97%
Dec 31, 2023
175.51M41.48M+30.95%
Dec 31, 2022
134.03M88.42M+193.89%
Dec 31, 2021
45.60M-4.51M-9.00%
Dec 31, 2020
50.12M49.80M+15,660.38%
Dec 31, 2019
318.00K-145.00K-31.32%
Dec 31, 2018
463.00K43.00K+10.24%
Dec 31, 2017
420.00K247.00K+142.77%
Dec 31, 2016
173.00K
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis